Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
30
TIL Quote, Financials, Valuation and Earnings
Last price:
$21.70
Seasonality move
:
18.67%
Day range:
$20.70 - $21.90
52-week range:
$7.10 - $92.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.81x
Volume:
56.3K
Avg. volume:
117.2K
1-year change:
208.31%
Market cap:
$142.9M
Revenue:
--
EPS (TTM):
-$11.56
Analysts' Opinion
-
Consensus RatingInstil Bio has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Instil Bio has an estimated upside of 358.35% from its current price of $21.89.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $21.89.
Fair Value
-
According to the consensus of 0 analysts, Instil Bio has 358.35% upside to fair value with a price target of -- per share.
TIL vs. S&P 500
-
Over the past 5 trading days, Instil Bio has underperformed the S&P 500 by -1.97% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Instil Bio does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Instil Bio has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Instil Bio reported revenues of --.
Earnings Growth
-
Instil Bio has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Instil Bio reported earnings per share of -$3.54.
Enterprise value:
104.7M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.53x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$223.4M | -$107.9M | -$57.4M | -$20.4M | -$11.3M | |
| EBITDA | -$219.2M | -$188.1M | -$63.5M | -$64.5M | -$20.1M | |
| Diluted EPS | -$34.80 | -$30.21 | -$11.56 | -$10.37 | -$3.54 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $523.1M | $313.7M | $195.6M | $132.6M | |
| Total Assets | -- | $647.4M | $532.7M | $340.3M | $272.6M | |
| Current Liabilities | -- | $32.1M | $42.1M | $13.5M | $10.3M | |
| Total Liabilities | -- | $46M | $122.2M | $106.2M | $96.2M | |
| Total Equity | -- | $601.4M | $410.6M | $234M | $176.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$186M | -$105.6M | -$58.5M | -$14.4M | -$20.1M | |
| Cash From Investing | $141.7M | $60M | $54.9M | $2.3M | $19.8M | |
| Cash From Financing | $65.9M | $14.3M | $159K | -$587K | $159K | |
| Free Cash Flow | -$276M | -$139.2M | -$68.6M | -$19.6M | -$30.1M | |
TIL
Sector
Market Cap
$142.9M
$46.1M
Price % of 52-Week High
23.79%
46.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
208.31%
-30.52%
Beta (5-Year)
--
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$21.27
200-day SMA
Buy
Level
$20.92
Bollinger Bands (100)
Sell
Level
13.23 - 48.13
Chaikin Money Flow
Sell
Level
-58.6M
20-day SMA
Sell
Level
$24.28
Relative Strength Index (RSI14)
Sell
Level
41.51
ADX Line
Buy
Level
12.04
Williams %R
Neutral
Level
-75.2589
50-day SMA
Sell
Level
$28.37
MACD (12, 26)
Sell
Level
-2.34
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Sell
Level
-29M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Stock Forecast FAQ
In the current month, TIL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TIL average analyst price target in the past 3 months is --.
-
Where Will Instil Bio Stock Be In 1 Year?
According to analysts, the consensus estimate is that Instil Bio share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Instil Bio?
Analysts are divided on their view about Instil Bio share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Instil Bio is a Sell and believe this share price will drop from its current level to --.
-
What Is Instil Bio's Price Target?
The price target for Instil Bio over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TIL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Instil Bio is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of TIL?
You can purchase shares of Instil Bio via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Instil Bio shares.
-
What Is The Instil Bio Share Price Today?
Instil Bio was last trading at $21.70 per share. This represents the most recent stock quote for Instil Bio. Yesterday, Instil Bio closed at $21.89 per share.
-
How To Buy Instil Bio Stock Online?
In order to purchase Instil Bio stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
